As per the report, the size of the Europe pen needles market is expected to reach USD 1.07 billion by 2024 from USD 0.67 billion in 2019, growing at a CAGR of 10.00% for the next five years 2019 - 2024.
Pen needles are used to deliver the medication (such as insulin or other injectable medications) in combination with injection pens. A pen needle comprises of hollow needle attached to injection pen. Pen needles are available with varied needle lengths and are majorly utilized by diabetes patients.
Growing rate of diabetic patients, existence of favorable regulatory policies to reduce needle stick injuries, increasing government focus on the utilization of safety devices, growing funding resources for diabetes care & research in the U.K., and presence of favorable reimbursement policies in Germany are driving the growth of pen needles market in Europe. In addition, increasing number of aging population & availability of high insurance in France, growing number of diabetes awareness programs in Italy, and existence of regulations that mandate the utilization of safety pen needles & presence of huge diabetic population in Spain are further driving the growth of the market in Europe.
However, lack of awareness on the pen needles utilization and presence of uncertain reimbursement policies across Europe are restraining the growth of pen needles market in Europe.
This research report segmented and sub-segmented into the following categories:
By Therapy: Insulin Therapy, GLP-1 Therapy & Growth Hormone Therapy
Based on therapy, insulin therapy is estimated to command the largest share of the Europe pen needles market in 2018 and expected to grow at the highest CAGR during the forecast period.
By Type: Standard Needle & Safety Needle
Based on type, standard pen needle segment is estimated to account for larger share of Europe pen needles market in 2018, whereas safety pen needles segments is estimated to grow at a higher CAGR for the next five years.
By Needle Length: 4mm, 6mm, 8mm, 10mm, 12mm
Among the length of pen needles, 8mm is estimated to command for the largest share of the Europe pen needles market in 2016 and 4mm is expected to grow at the highest CAGR during the forecast period.
By Mode of Purchase: Retail & Non-Retail
Based on the mode of purchase, retail purchase mode is estimated to account for the larger share of the Europe pen needles market in 2018 and expected to grow at a higher CAGR for the next five years.
By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe
On the basis of geographical areas, Germany is estimated to account for the largest share of the Europe pen needles market in 2018, whereas France is estimated to grow at the highest CAGR during the forecast period.
Most promising companies in the Europe Pen Needles market:
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1.2 Insulin Therapy
5.1.3 GLP-1 Therapy Growth Hormone Therapy
5.1.4 Growth Hormone Therapy
5.2.2 Standard Needle
5.2.3 Safety Needle
5.3 Needle Length
5.4 Mode of Purchase
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1 Becton, Dickinson and Company (U.S.)
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Novo Nordisk A/S (Denmark)
8.3 Ypsomed Holding AG (Switzerland)
8.4 UltiMed, Inc. (U.S.)
8.5 Allison Medical, Inc. (U.S.)
8.6 Owen Mumford, Ltd. (U.K.)
8.7 B. Braun Melsungen (Germany)
8.8 Artsana S.p.a. (Italy)
8.9 HTL-STREFA S.A. (Poland)
8.10 Terumo Corporation (Japan)
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.1 Market Outlook
10.2 Investment Opportunities